Dalfopristin
| Title | Journal |
|---|---|
| [In vitro activities of quinupristin/dalfopristin in combination with vancomycin and gatifloxacin against Staphylococcus aureus and Enterococcus faecium clinical isolates]. | Mikrobiyoloji bulteni 20090101 |
| New treatment options and protocols for peritoneal dialysis-related peritonitis. | Contributions to nephrology 20090101 |
| [Persistent bacteremia caused by methicillin-resistant Staphylococcus aureus]. | Enfermedades infecciosas y microbiologia clinica 20081101 |
| A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20080601 |
| Transposon characterization of vancomycin-resistant Enterococcus faecium (VREF) and dissemination of resistance associated with transferable plasmids. | The Journal of antimicrobial chemotherapy 20070801 |
| [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens]. | Recenti progressi in medicina 20070301 |
| In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus. | Indian journal of medical microbiology 20070101 |
| Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20061201 |
| Prevalence of macrolide resistance genes among staphylococci in Cyprus. | Journal of chemotherapy (Florence, Italy) 20061001 |
| Emergence of Enterococcus faecalis susceptible to quinupristin/dalfopristin in Greece. | International journal of antimicrobial agents 20060801 |
| Antimicrobial susceptibility and molecular analysis of Enterococcus faecalis originating from endodontic infections in Finland and Lithuania. | Oral microbiology and immunology 20060601 |
| In vitro activity of quinupristin and dalfopristin in combination and alone against coryneform bacteria. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20051101 |
| In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals. | The Medical journal of Malaysia 20051001 |
| Emergence of Staphylococcus hominis strains expressing low-level resistance to quinupristin/dalfopristin in Greece. | The Journal of antimicrobial chemotherapy 20050501 |
| In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections. | The Journal of antimicrobial chemotherapy 20050201 |
| In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci. | The Indian journal of medical research 20041201 |
| In vitro activity of telithromycin, quinupristin/dalfopristin, linezolid and comparator antimicrobial agents against Staphylococcus aureus clinical isolates. | Journal of chemotherapy (Florence, Italy) 20040601 |
| Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin. | BMC biology 20040101 |
| Sequence and genetic organization of the 19.3-kb erythromycin- and dalfopristin-resistance plasmid pLME300 from Lactobacillus fermentum ROT1. | Plasmid 20031101 |
| What is the role of streptogramins in intensive care? | Journal of chemotherapy (Florence, Italy) 20031101 |
| Role of quinupristin/dalfopristin in the treatment of Gram-positive nosocomial infections in haematological or oncological patients. | Cancer treatment reviews 20031001 |
| Quinupristin/dalfopristin-induced Sweet's syndrome. | The Korean journal of internal medicine 20030901 |
| Structural basis of Synercid (quinupristin-dalfopristin) resistance in Gram-positive bacterial pathogens. | The Journal of biological chemistry 20030808 |
| Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin. | Southern medical journal 20030801 |
| Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. | The Journal of parasitology 20030801 |
| Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium. | Diagnostic microbiology and infectious disease 20030301 |
| [Other antimicrobial agents (linezolid, quinupristin/dalfopristin, glycylcycline etc)]. | Nihon rinsho. Japanese journal of clinical medicine 20030301 |
| [Other antimicrobials (linezolid, quinupristin/dalfopristin)]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| Treatment of life-threatening multiresistant staphylococcal and enterococcal infections in patients with end-stage renal failure with quinupristin/dalfopristin: preliminary report. | Infection 20021001 |
| Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20021001 |
| Safety and efficacy of quinupristin/dalfopristin for treatment of invasive Gram-positive infections in pediatric patients. | The Pediatric infectious disease journal 20021001 |
| Quinupristin/dalfopristin. | Expert opinion on pharmacotherapy 20020901 |
| Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci. | Intensive care medicine 20020801 |
| Combination of quinupristin/dalfopristin and glycopeptide in severe methicillin-resistant staphylococcal infections failing previous glycopeptide regimens. | Infection 20020601 |
| [symbol: see text]Quinupristin + dalfopristin for infections. | Drug and therapeutics bulletin 20020201 |
| Quinupristin-dalfopristin: a new antibiotic for severe gram-positive infections. | American family physician 20011201 |
| Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. | The New England journal of medicine 20011018 |
| Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children. | International journal of antimicrobial agents 20010301 |
| Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics. | The Medical clinics of North America 20010101 |
| Quinupristin/dalfopristin: a therapeutic review. | Clinical therapeutics 20010101 |
| Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany. | Microbial drug resistance (Larchmont, N.Y.) 20010101 |
| Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapy--a status report. | Current clinical topics in infectious diseases 20010101 |
| [Quinupristin/dalfopristin]. | Revista de medicina de la Universidad de Navarra 20010101 |
| Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections. | Drugs 19991201 |
| Quinupristin-dalfopristin is active against Toxoplasma gondii. | Antimicrobial agents and chemotherapy 19990801 |